ENvue Medical, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| MIKA THOMAS | — | Purchase | 50,000 | $0.25 | $12,500 | 50,000 | Jan 5, 2023 |
| FASHEK CHRISTOPHER M | — | Purchase | 40,000 | $0.60 | $24,000 | 75,000 | Jun 15, 2022 |
| BROWN STEPHEN RUSSELL | Chief Financial Officer | Purchase | 4,000 | $0.57 | $2,280 | 4,000 | Jun 14, 2022 |
| Cassirer Aurora | — | Purchase | 2,000 | $0.69 | $1,380 | 2,000 | Jun 1, 2022 |
| FASHEK CHRISTOPHER M | — | Purchase | 10,000 | $0.79 | $7,900 | 10,000 | Sep 29, 2020 |
| FASHEK CHRISTOPHER M | — | Purchase | 25,000 | $2.00 | $50,000 | 25,000 | Nov 20, 2019 |